Evidence map›Paper›PMID 33355966›Full record

ArticleInternational journal of methods in psychiatric research2021

Relationship between clinical outcomes measures and personal and social performance functioning in a prospective, interventional study in schizophrenia.

Roland Vauth, Bernardo Carpiniello, Jacek Turczyński, Mikhail Ivanov, Pierre Cherubin, Marjolein Lahaye, Andreas Schreiner

Abstract read
In one paragraph

Article in International journal of methods in psychiatric research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Roland VauthCenter for Mental Health, Department of Psychiatry and Psychotherapy, University Hospital of Psychiatry Basel, University of Basel, Basel, Switzerland.ORCID 0000-0001-8711-1245
Bernardo CarpinielloUnit of Psychiatry, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
Jacek TurczyńskiDepartment of Developmental, Psychotic, and Geriatric Psychiatry, Medical University of Gdańsk, Gdańsk, Poland.
Mikhail IvanovSt Petersburg Psychoneurological Research Institute, St Petersburg, Russia.
Pierre CherubinMedical Affairs EMEA, Janssen-Cilag, Issy-les-Moulineaux, France.
Marjolein LahayeMedical Affairs EMEA, Janssen-Cilag BV, Breda, Netherlands.
Andreas SchreinerMedical & Scientific Affairs EMEA, Janssen-Cilag GmbH, Neuss, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo explore clinical and demographic characteristics impacting patient functioning by determining extent of overlap in factors driving change in Personal and Social Performance (PSP) and other clinical outcomes.

methodsPost-hoc analysis from a single-arm trial of paliperidone extended release in adult patients with nonacute symptomatic schizophrenia. Psychosocial functioning measures: PSP, Clinical Global Impression-Severity (CGI-S), Positive and Negative Syndrome Scale (PANSS), Short-Form 36 (SF-36), treatment satisfaction, sleep quality/daytime drowsiness, and Extrapyramidal Symptoms Rating Scale.

resultsHighest correlations with PSP total score change included PANSS total score change (Spearman's r = 0.607), PANSS general psychopathology change (r = 0.579), and CGI-S change (r = 0.569). A PSP score change of -32 predicted 90% probability of deterioration in CGI-S (score change of ≥1). The power of PSP change to predict PANSS total score change was lower. Linear stepwise regression demonstrated independent relationships for PSP change and: PANSS total change; CGI-S change; SF-36 Mental Component change; treatment satisfaction at endpoint; PSP at baseline; previous psychiatric hospitalizations. R

conclusionsPsychosocial functioning improvement is important in schizophrenia. PSP may be valuable for assessing functioning; it encompasses psychosocial and clinical factors not measured by other established assessments.

Indexed as

Antipsychotic AgentsSchizophreniaAdultHumansPaliperidone PalmitateProspective StudiesSchizophrenic PsychologySocial AdjustmentAntipsychotic AgentsPaliperidone Palmitateclinical outcomespsychosocial functioningschizophrenia

Identifiers

PMID33355966
PMCPMC8170566

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.